Search

Your search keyword '"Peptide Hormones therapeutic use"' showing total 140 results

Search Constraints

Start Over You searched for: Descriptor "Peptide Hormones therapeutic use" Remove constraint Descriptor: "Peptide Hormones therapeutic use"
140 results on '"Peptide Hormones therapeutic use"'

Search Results

1. Eight weeks of daily cottonseed oil intake attenuates postprandial angiopoietin-like proteins 3 and 4 responses compared to olive oil in adults with hypercholesterolemia: A secondary analysis of a randomized clinical trial.

2. Angiopoietin-Like Proteins: Cardiovascular Biology and Therapeutic Targeting for the Prevention of Cardiovascular Diseases.

3. Therapeutic potential of apelin and Elabela in cardiovascular disease.

4. Cardiovascular aspects of ELABELA: A potential diagnostic biomarker and therapeutic target.

5. Efficacy and safety of Shouhui Tongbian Capsules in the treatment of constipation: A systematic review and meta-analysis.

6. Angiotensinogen: More Than its Downstream Products: Evidence From Population Studies and Novel Therapeutics.

7. Phoenixin-20 ameliorates brain infarction by promoting microglia M2 polarization in an ischemic stroke model.

8. Phoenixin-20 ameliorates gestational diabetes mellitus (GDM) symptoms and placental insults in an experimental mouse model.

9. ANGPTL3 as therapeutic target.

10. Nuclear hormone and peptide hormone therapeutics for NAFLD and NASH.

11. ELABELA alleviates syncytiotrophoblast hypoxia/reoxygenation injury and preeclampsia-like symptoms in mice by reducing apoptosis.

12. Phoenixin 14 inhibits ischemia/reperfusion-induced cytotoxicity in microglia.

13. "Spexin improves adipose tissue inflammation and macrophage recruitment in obese mice".

14. Intermedin 1-53 attenuates aging-associated vascular calcification in rats by upregulating sirtuin 1.

15. Recombinant Fc-Elabela fusion protein has extended plasma half-life andmitigates post-infarct heart dysfunction in rats.

16. Hydrogels For Peptide Hormones Delivery: Therapeutic And Tissue Engineering Applications.

17. Evaluation and management of ketosis-prone diabetes.

18. Melatonin as a Hormone: New Physiological and Clinical Insights.

19. Inhibition of endoplasmic reticulum stress by intermedin1-53 attenuates angiotensin II-induced abdominal aortic aneurysm in ApoE KO Mice.

20. Glucagon-Like Peptide-1 (GLP-1)-Based Therapeutics: Current Status and Future Opportunities beyond Type 2 Diabetes.

21. Adrenomedullin 2/intermedin: a putative drug candidate for treatment of cardiometabolic diseases.

22. The apelinergic system as an alternative to catecholamines in low-output septic shock.

23. Small Bioactive Peptides for Biomaterials Design and Therapeutics.

24. ELABELA and an ELABELA Fragment Protect against AKI.

25. Hybrid peptides in the landscape of drug discovery.

26. Elabela/Toddler Is an Endogenous Agonist of the Apelin APJ Receptor in the Adult Cardiovascular System, and Exogenous Administration of the Peptide Compensates for the Downregulation of Its Expression in Pulmonary Arterial Hypertension.

27. Peptide hormones and lipopeptides: from self-assembly to therapeutic applications.

28. Heart Peptide Hormones: Adjunct and Primary Treatments of Cancer.

29. Regulation of Hepatocellular Fatty Acid Uptake in Mouse Models of Fatty Liver Disease with and without Functional Leptin Signaling: Roles of NfKB and SREBP-1C and the Effects of Spexin.

30. Hypoglycemia unawareness prevention: Targeting glucagon production.

31. Modulation of hepcidin to treat iron deregulation: potential clinical applications.

32. A lipasin/Angptl8 monoclonal antibody lowers mouse serum triglycerides involving increased postprandial activity of the cardiac lipoprotein lipase.

33. Betatrophin in Diabetes Mellitus: the Epidemiological Evidence in Humans.

34. Peptides: Basic determinants of reproductive functions.

35. Apelin, Elabela/Toddler, and biased agonists as novel therapeutic agents in the cardiovascular system.

36. The role of ghrelin on apoptosis, cell proliferation and oxidant-antioxidant system in the liver of neonatal diabetic rats.

37. Antioxidant Defense System after Single and Chronic Administration of Obestatin and Its Fragment (1-4) to Normal and Overweight Male Rats.

39. Angiotensin-(1-7): a peptide hormone with anti-cancer activity.

40. Mechanism and novel therapeutic approaches to wasting in chronic disease.

41. Cardiac hormones for the treatment of cancer.

42. The Year in Cardiology 2012: heart failure.

43. [Betatrophin - the turn in diabetes treatment].

44. Bowels control brain: gut hormones and obesity.

45. Inhibition of endoplasmic reticulum stress by intermedin(1-53) protects against myocardial injury through a PI3 kinase-Akt signaling pathway.

46. Ghrelin and appetite control in humans--potential application in the treatment of obesity.

47. Decreased cerebrospinal fluid/plasma ratio of the novel satiety molecule, nesfatin-1/NUCB-2, in obese humans: evidence of nesfatin-1/NUCB-2 resistance and implications for obesity treatment.

48. Use of analogs of peptide hormones conjugated to cytotoxic radicals for chemotherapy targeted to receptors on tumors.

49. Peptide hormone isoforms: N-terminally branched PYY3-36 isoforms give improved lipid and fat-cell metabolism in diet-induced obese mice.

50. Metabolic and structural properties of human obestatin {1-23} and two fragment peptides.

Catalog

Books, media, physical & digital resources